Sun Pharmaceutical Industries Ltd. has announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, Inc., an immunotherapy and targeted oncology company, in a $355 million cash deal.

The pharmaceutical industry is witnessing significant shifts, not only in its research and development processes but also in the way medications are packaged. Pharmaceutical packaging is essential ...

Verona Pharma plc (NASDAQ:VRNA – Get Free Report)’s stock price gapped down before the market opened on Friday after an insider sold shares in the company. The stock had previously closed at $ ...

Stock Market Today: Indian pharma stocks faced significant selling pressure in today's session, February 19, after U.S. President Donald Trump announced that he would impose duties on ...

Der Jade-Weser-Port ist Deutschlands einziger Tiefwasserhafen. Zwei Seehafen-Experten erklären, wieso sich das bald doch noch für Bremen und Niedersachen auszahlen könnte. Der Jade-Weser-Port ...

Novartis has teamed up with the NFL in a multi-year partnership, marking the first such collaboration between the football league and a pharmaceutical company. The partnership will center around ...

Indian pharmaceutical companies are aggressively expanding their US presence through a wave of acquisitions, likely as a hedge against future uncertainties. Leading players like Sun Pharma ...

The companies behind the product pulls are Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, all three of which hail from India. The drugmakers are recalling seizure treatments ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to ...

J.P. Morgan on Wednesday launched its coverage of ANI Pharmaceuticals (NASDAQ:ANIP) with an Overweight recommendation and a year-end price target of $85 per share, citing the specialty pharma ...

Die dänische Zealand Pharma verzeichnet aktuell bedeutende Entwicklungen in ihrem Forschungsportfolio und steht daher im Fokus von Marktteilnehmern. Die Aktie notiert derzeit bei 78,85 Euro und ...

India is expecting nearly ₹17,000 crore of investment towards R&D in the pharma sector by FY28, covering segments such as cancer research, lifestyle disease prevention, med-tech and devices ...